Summary
In 2025, a KFF Tracking Poll found that one in eight Americans was taking an injection of a GLP-1 medication such as semaglutide or tirzepatide for weight loss. Today, thats changing dramatically as folks opt for one of the two newly approved …
Source: Arcamax
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
